Toronto Precision Epoxy Flooring installs pharmaceutical and cleanroom epoxy flooring systems engineered for controlled environments where contamination control, cleanability, and regulatory compliance are critical. These systems create seamless, non-porous, and chemically resistant surfaces for cleanrooms, laboratories, sterile production areas, and controlled manufacturing facilities across Toronto. Designed to meet ISO 5–8 cleanroom standards and GMP requirements, our flooring systems eliminate dusting, prevent microbial harborage, and withstand continuous cleaning and sterilization cycles using agents such as isopropyl alcohol (IPA), hydrogen peroxide, and bleach solutions while maintaining long-term adhesion and surface integrity.
Cleanroom and pharmaceutical environments operate under conditions where even minor surface defects can compromise product quality and compliance. Concrete substrates are inherently porous and can transmit moisture vapour (~3–10+ lbs/1000 sq ft/24 hrs, ASTM F1869), allowing contaminants, bacteria, and chemicals to penetrate untreated surfaces. Frequent sanitation cycles, chemical exposure, and controlled airflow environments require flooring systems that remain fully sealed, chemically stable, and resistant to degradation. Without proper system design, coatings can develop pinholes, lose adhesion, or deteriorate under repeated cleaning and chemical exposure.
Epoxy and resinous flooring systems used in pharmaceutical and cleanroom facilities typically include moisture-tolerant epoxy primers, high-build 100% solids epoxy base systems, and specialized chemical-resistant layers such as novolac epoxy. In high-exposure or washdown areas, urethane cement systems may be specified for their resistance to thermal cycling and moisture. Seamless integration with 4″–6″ integral cove bases eliminates floor-to-wall joints, while slip-resistant broadcast systems can be incorporated where required without compromising cleanability. Protective topcoats such as polyurethane or polyaspartic enhance chemical resistance, abrasion resistance, and long-term performance under continuous controlled-environment operation.
We provide pharmaceutical and cleanroom epoxy flooring services throughout Toronto and the Greater Toronto Area, including Mississauga, Brampton, Vaughan, Markham, Richmond Hill, Oakville, Burlington, Milton, Scarborough, North York, Etobicoke, Pickering, Ajax, Whitby, Oshawa, and surrounding industrial zones. Every installation is completed with detailed surface preparation, contamination control planning, and system design tailored to cleanroom classifications and operational requirements, ensuring long-term performance and compliance in controlled environments.
Tell us about your project and we’ll recommend the right system—no guesswork, no one-size-fits-all solutions.
✔ 20+ Years of Epoxy Flooring Experience
✔ Residential, Commercial and Industrial Expertise
✔ Industrial-Grade Surface Preparation
✔ Moisture Testing & Mitigation Systems
✔ Premium Epoxy & Coating Systems
✔ Built for Local Climate Conditions
✔ Durable, Long-Lasting Element-Resistant Flooring
✔ Custom-Tailored Flooring Solutions
We’ll contact you within 24 hours to review your project and next steps.
We look forward to learning more about your project and helping you get the right flooring system in place.




Pharmaceutical and cleanroom flooring systems are engineered for environments where contamination control, sterile processing, and regulatory compliance are critical. Floors are routinely exposed to continuous foot traffic, controlled airflow systems, equipment movement, and repeated cleaning cycles using disinfectants such as isopropyl alcohol (IPA), hydrogen peroxide, and sodium hypochlorite. Systems must be seamless, non-porous, and built using high-build 100% solids epoxy, novolac epoxy, or urethane-based systems to maintain adhesion, chemical resistance, and long-term hygienic performance under ISO-classified and GMP-regulated conditions.
Cleanroom environments require flooring systems that minimize particulate generation and eliminate contamination pathways. Seamless epoxy systems installed at 20–40 mils provide non-shedding, non-porous surfaces that support controlled airflow and cleanliness standards. Integral cove bases (4″–6″) eliminate floor-to-wall joints, preventing particle accumulation and simplifying sterilization protocols.
Production and packaging zones involve continuous equipment operation, personnel movement, and strict hygiene requirements. Flooring systems are designed to resist abrasion from carts and equipment while maintaining chemical resistance to cleaning agents and process residues. High-build epoxy systems with durable topcoats maintain surface integrity under repeated sanitation cycles and operational wear.
Laboratory environments require chemically stable flooring systems that resist exposure to reagents, solvents, and cleaning chemicals without surface degradation. Novolac epoxy systems are often specified for their superior resistance to chemical attack, preventing staining, softening, or coating breakdown under repeated exposure while maintaining a smooth, cleanable surface.
Sterile compounding areas demand flooring systems with zero porosity and seamless integration to prevent microbial harborage. Systems incorporate fully sealed surfaces with consistent thickness and adhesion (≥250–350 PSI pull-off strength) to maintain integrity under strict cleaning protocols and controlled environmental conditions.
Areas subjected to frequent washdowns and chemical sterilization require flooring systems that maintain adhesion under wet conditions and repeated exposure to disinfectants. Urethane or chemical-resistant epoxy systems are used to prevent osmotic blistering, coating breakdown, and moisture-related failure while maintaining a safe, slip-resistant surface.
Mechanical and support areas within pharmaceutical facilities require durable flooring systems that balance chemical resistance with moderate mechanical performance. High-build epoxy systems provide abrasion resistance and cleanability while supporting maintenance operations and equipment servicing without compromising hygienic standards.
Entry points between controlled and non-controlled environments must maintain consistent flooring performance to prevent contamination transfer. Seamless systems with integrated coving and uniform thickness eliminate joints and transitions where particles or contaminants could accumulate, supporting controlled movement between zones.
Storage and staging areas require flooring systems that maintain cleanliness while handling moderate rolling loads from carts and material movement. Non-porous epoxy systems reduce dusting, improve cleanability, and maintain surface durability under continuous operational use within controlled environments.
Pharmaceutical and cleanroom flooring systems are engineered for environments where contamination control, chemical resistance, and regulatory compliance are critical under continuous operation. Unlike general industrial settings, these facilities require seamless, non-porous surfaces that prevent particulate generation, resist aggressive disinfectants, and maintain integrity under repeated sterilization cycles. High-performance systems such as high-build 100% solids epoxy, novolac epoxy, and specialized resinous coatings are used to create dense, impermeable surfaces that support ISO-classified cleanrooms and GMP-regulated environments.



Pharmaceutical and cleanroom facilities require flooring systems engineered to perform in controlled environments where contamination control, chemical resistance, and cleanability are critical under continuous operation. These systems are installed as seamless, multi-layer builds incorporating mechanical surface preparation (typically CSP 2–4 for coatings and CSP 3–5 for higher-build systems), moisture-tolerant epoxy primers, high-build 100% solids epoxy or novolac base layers, and chemically resistant topcoats. System specifications are driven by cleanroom classification (ISO 5–8), chemical exposure, sanitation frequency, and regulatory requirements to ensure long-term adhesion, non-porous performance, and resistance to chemical degradation.
High-build epoxy systems are typically installed at 20–40 mils (0.5–1.0 mm) to create dense, non-porous, and non-shedding surfaces suitable for cleanrooms and controlled production areas. Installed over properly prepared CSP 2–4 profiles, these systems deliver compressive strengths in the range of 10,000–14,000 PSI while maintaining smooth, cleanable finishes that resist dusting and surface contamination.
In environments exposed to frequent sterilization and chemical cleaning, novolac epoxy systems are specified for their high cross-link density and resistance to aggressive agents such as hydrogen peroxide, IPA, bleach, and quaternary disinfectants. These systems prevent softening, staining, and long-term resin degradation under repeated chemical exposure.
Integral cove base systems—typically installed at 4″–6″—create continuous transitions between floors and walls, eliminating joints where contaminants can accumulate. Seamless integration around drains, penetrations, and equipment bases ensures a fully sealed system that supports GMP compliance and simplifies cleaning and inspection processes.
Quartz or silica broadcast systems may be incorporated into epoxy layers to reinforce wear surfaces in areas with cart traffic or equipment movement. Installed at 30–60 mils, these systems improve abrasion resistance while maintaining a cleanable, chemically resistant surface without generating particulate under controlled conditions.
Concrete substrates in controlled environments are evaluated for moisture vapour transmission (MVT) using ASTM F2170 (in-situ RH) or ASTM F1869 (calcium chloride). Where required, moisture-tolerant epoxy primers are applied to handle levels up to ~75–100% RH or ~12–20 lbs/1000 sq ft/24 hrs, preventing osmotic blistering, adhesion loss, and coating failure under sealed conditions.
Protective topcoats are applied at approximately 6–12 mils to enhance chemical resistance, abrasion resistance, and long-term surface durability. Polyurethane coatings provide flexibility and resistance to cleaning wear, while polyaspartic systems offer faster cure times and rapid return-to-service, making them suitable for phased installations in active cleanroom environments.
Slip-resistant aggregates such as aluminum oxide or silica are incorporated where required to improve traction in wet or frequently sanitized areas. Surface profiles are engineered to balance slip resistance with cleanability, ensuring safe movement of personnel while maintaining hygienic performance.
Control joints are treated using chemical-resistant epoxy or polyurea joint fillers to prevent edge deterioration and contamination pathways. Seamless system integration across slabs, joints, and transitions ensures consistent thickness, eliminates failure points, and maintains long-term performance under continuous cleanroom operation.
Pharmaceutical and cleanroom epoxy flooring systems are installed as precision-engineered, multi-layer builds designed to maintain contamination control, chemical resistance, and seamless performance under continuous GMP-regulated operation. These environments demand non-porous systems that resist chemical exposure, withstand aggressive cleaning protocols, and maintain adhesion under controlled temperature and humidity conditions. System design is driven by ISO cleanroom classification (typically ISO 5–8), sanitation frequency, and chemical exposure to ensure long-term durability, cleanability, and regulatory compliance.

1. Surface Preparation & Concrete Profiling (CSP)
Concrete is mechanically prepared to remove contaminants and achieve the required surface profile for proper adhesion. (see more details in Surface Preparation section)
A two-component moisture-tolerant epoxy primer is applied at approximately 6–10 mils to penetrate and seal the substrate while establishing a high-strength mechanical bond. In controlled environments where slabs may experience moisture vapour transmission or frequent washdowns, primers are specified to tolerate up to ~75–100% RH (ASTM F2170) or ~12–20 lbs/1000 sq ft/24 hrs (ASTM F1869), preventing osmotic blistering, microbial intrusion pathways, and long-term adhesion loss beneath sealed flooring systems.
3. Base Layer (High-Build Epoxy, Novolac Epoxy, or Epoxy Mortar)
The base layer provides structural integrity, chemical resistance, and a non-shedding surface. High-build 100% solids epoxy systems are typically installed at 20–40 mils to create dense, impermeable coatings for controlled environments. In areas exposed to aggressive disinfectants or chemical agents, novolac epoxy systems are used for their high cross-link density and resistance to acids, solvents, and oxidizing cleaners. Where substrate deterioration or higher load capacity is required, epoxy mortar systems—installed at 1/8″–1/4″ (3–6 mm)—deliver compressive strengths exceeding 14,000 PSI while maintaining dimensional stability.
Functional system components are integrated based on cleanroom classification and operational requirements. Smooth, low-profile broadcast systems may be installed at 20–40 mils to enhance wear resistance without increasing particle retention. In wet-processing or frequent sanitation zones, slip-resistant aggregates such as fine silica or aluminum oxide are incorporated to improve traction while maintaining cleanability. Additional localized reinforcement may be applied in equipment zones or transition areas to ensure uniform system performance and eliminate contamination-prone defects.
5. Protective Topcoat & System Performance Layer
Protective topcoats are applied at approximately 6–12 mils using polyurethane or polyaspartic coatings to enhance chemical resistance, surface durability, and long-term cleanability. These layers create a sealed, non-porous surface resistant to staining, repeated sanitation cycles, and surface wear, while supporting consistent environmental control and compliance with pharmaceutical and cleanroom operational standards.
Pharmaceutical and cleanroom environments require concrete preparation processes engineered for contamination control, regulatory compliance, and long-term coating integrity under controlled temperature, humidity, and sanitation conditions. Floors are routinely exposed to disinfectants, cleaning agents (e.g., hydrogen peroxide, quaternary ammonium compounds), and frequent washdowns, while maintaining strict particulate control (ISO 5–8). Proper surface preparation ensures the substrate achieves required bond strength, eliminates contamination pathways, and supports seamless, non-porous resinous systems that maintain adhesion and cleanability under continuous GMP-regulated operation.
Concrete is mechanically prepared using industrial diamond grinding or shot blasting to achieve a Concrete Surface Profile (CSP) typically in the range of 3–5 for high-build coatings and CSP 4–6 for thicker resinous or mortar systems. This process removes laitance, weak surface layers, curing compounds, and embedded contaminants while opening the pore structure for mechanical interlock. Target substrate compressive strength is typically ≥3,500–5,000 PSI, with pull-off adhesion values of ≥250–350 PSI after preparation to ensure coating performance in controlled environments.
Cleanroom and pharmaceutical slabs are frequently exposed to cleaning chemicals, sanitizers, and process residues that can penetrate the concrete matrix. These contaminants must be fully removed using mechanical grinding, controlled degreasing, and, where required, neutralization of chemical residues. Any remaining contamination acts as a bond breaker, increasing the risk of blistering, microbial entrapment, or coating failure under repeated sanitation cycles.
Existing coatings, sealers, adhesives, or failed systems must be completely removed to expose sound concrete. Surface defects such as spalling, cracking, joint edge deterioration, or chemical erosion are repaired using epoxy patching compounds or chemical-resistant epoxy mortar systems. In deteriorated areas, localized resurfacing at 1/8″–1/4″ (3–6 mm) may be required to restore substrate integrity and create a uniform, defect-free surface suitable for seamless installation.
4. Surface Leveling, Hygienic Transitions & Drainage Preparation
Cleanroom floors require tight flatness and smooth transitions to support controlled environments and cleaning efficiency. Grinding, leveling, and localized resurfacing are performed to eliminate slab irregularities, joints, and transition points that can harbor contaminants. Where applicable, slope-to-drain design (typically 1–2%) is incorporated in washdown zones to ensure effective liquid management while maintaining a seamless, cleanable surface profile.
Concrete slabs are evaluated for moisture vapour transmission (MVT) using ASTM F2170 (in-situ RH) or ASTM F1869 (calcium chloride). Even in controlled environments, underlying moisture can compromise adhesion if not addressed. Moisture-mitigating primers are specified to tolerate up to ~75–100% RH or ~12–20 lbs/1000 sq ft/24 hrs depending on system design. Final preparation includes thorough vacuuming and controlled cleaning to ensure a dust-free, dry, and contamination-free substrate ready for high-performance cleanroom flooring systems.
Effective surface preparation in pharmaceutical and cleanroom environments is focused on achieving a contamination-free, mechanically sound substrate with consistent surface profile and bond strength. When executed to specification, the flooring system supports seamless installation, resists chemical and cleaning-induced degradation, and maintains long-term performance within tightly controlled operational and regulatory conditions.
Pharmaceutical and cleanroom epoxy flooring systems are engineered for contamination control, chemical resistance, and continuous sanitation under tightly regulated conditions. However, failures occur when surface preparation, system selection, or installation methods do not align with ISO classification requirements, chemical exposure levels, and cleaning protocols. In these environments, coating breakdown is rarely caused by a single issue—it typically results from the combined effects of chemical attack, moisture intrusion, mechanical wear, and improper system specification over time.
Long-term performance in pharmaceutical and cleanroom environments depends on aligning system design with contamination control requirements, chemical exposure levels, and maintenance protocols. When substrates are properly prepared, contaminants are eliminated, and systems are specified with appropriate chemistry and build thickness, epoxy flooring maintains a seamless, non-porous surface that supports hygiene standards, resists degradation, and performs reliably under continuous controlled-environment operation.
Pharmaceutical and cleanroom flooring installations are engineered around contamination control, chemical exposure, and strict regulatory standards under ISO-classified environments (typically ISO 5–8). These installations require controlled methods that account for substrate strength (typically ≥4,000–6,000+ PSI), moisture vapour transmission, surface cleanliness, and compatibility with continuous sanitation cycles. Proper execution ensures the flooring system maintains a seamless, non-porous surface, resists chemical degradation, and supports long-term performance in GMP-compliant environments.
Successful installation in pharmaceutical and cleanroom environments depends on precise coordination between substrate preparation, system chemistry, and environmental controls. When each phase is executed to specification, the result is a seamless, chemically resistant flooring system that supports hygiene standards, minimizes contamination risks, and performs reliably under continuous regulated use.
Yes. Epoxy and resinous flooring systems are widely used in ISO-classified cleanrooms (typically ISO 5–8) due to their seamless, non-porous properties and compatibility with GMP standards. High-build 100% solids epoxy systems (20–40 mils) and epoxy mortar systems (1/8″–1/4″ / 3–6 mm) provide durable, contamination-controlled surfaces that support regulated pharmaceutical operations.
Yes. Cleanroom floors are routinely exposed to disinfectants such as hydrogen peroxide, sodium hypochlorite, and quaternary ammonium compounds. Novolac epoxy systems and chemical-resistant topcoats are engineered to resist chemical attack, preventing softening, staining, and degradation under repeated cleaning cycles.
Yes. These systems are designed to handle continuous personnel movement, rolling carts, and equipment loads while maintaining a sealed, low-particulate surface. Properly installed systems over substrates ≥4,000–6,000 PSI with pull-off adhesion ≥250–350 PSI ensure long-term durability without delamination or surface breakdown.
Yes. Joints and transitions are treated using chemical-resistant fillers and seamless integration methods to eliminate gaps where contaminants can accumulate. Cracks and substrate defects are repaired with epoxy or mortar systems, creating a continuous surface that supports cleanability and contamination control.
Slip resistance can be engineered based on operational needs. Fine-texture broadcast systems using silica or aluminum oxide aggregates improve traction while maintaining cleanability. Surface profiles are carefully balanced to meet safety requirements without increasing particle retention or cleaning difficulty.
When properly specified and maintained, epoxy flooring systems in pharmaceutical environments typically last 8–15+ years. Longevity depends on factors such as chemical exposure intensity, cleaning frequency, and system thickness, with higher-build systems providing extended service life under aggressive conditions.
Yes. Installations can be phased and controlled to minimize contamination risks and operational downtime. Fast-curing systems, including polyaspartic or specialized resin systems, can reduce cure times while maintaining performance standards required in regulated environments.
Yes. Flooring is engineered by zone, including sterile cleanrooms, processing areas, corridors, airlocks, and maintenance zones. System type, thickness, and surface profile are tailored to specific requirements such as chemical resistance, cleanability, and traffic levels, ensuring each area meets performance standards without overbuilding the entire facility.
Have questions about pharmaceutical and cleanroom epoxy flooring? Request a free on-site assessment and we’ll evaluate your cleanroom classification, chemical exposure levels, and substrate conditions to recommend a system engineered for long-term, compliant performance.
Tell us about your project and we’ll recommend the right system—no guesswork, no one-size-fits-all solutions.
✔ 20+ Years of Epoxy Flooring Experience
✔ Residential, Commercial and Industrial Expertise
✔ Industrial-Grade Surface Preparation
✔ Moisture Testing & Mitigation Systems
✔ Premium Epoxy & Coating Systems
✔ Built for Local Climate Conditions
✔ Durable, Long-Lasting Element-Resistant Flooring
✔ Custom-Tailored Flooring Solutions
We’ll contact you within 24 hours to review your project and next steps.
We look forward to learning more about your project and helping you get the right flooring system in place.